Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05790239 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT05790239 · ClinicalTrials.gov record · last posted 2026-08-19

MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder

Name: MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder — clinical trial record (NCT05790239)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorStephen Robert Marder

Started2025-03-01

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This randomized, double-blind, single-site phase II 2-arm study will investigate the safety and preliminary efficacy of MDMA-assisted therapy compared with low dose d-amphetamine-assisted therapy on the severity of PTSD symptoms in participants aged 18 years and older with PTSD of at least moderate severity.

Protocol amendment history 2 changes detected by DataLookout

2026-08-20

Primary completion pushed: 2026-03 → 2028-03

2026-08-20

Completion pushed: 2026-03 → 2028-03-01

Trial Details

NCT Number	NCT05790239
Lead Sponsor	Stephen Robert Marder
Conditions	Post Traumatic Stress Disorder
Enrollment	40 participants
Start Date	2025-03-01
Primary Completion	2028-03 (estimated)
Study Completion	2028-03-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-19